GPD1L antibody (AA 1-351)
-
- Target See all GPD1L Antibodies
- GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))
-
Binding Specificity
- AA 1-351
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This GPD1L antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
- Immunogen
- Recombinant human GPD1L (1-351aa) purified from E. coli
- Clone
- AT14E2
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product GPD1L Primary Antibody
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
-
- Target
- GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))
- Alternative Name
- GPD1L (GPD1L Products)
- Background
- GPD1L is converts sn-glycerol 3-phosphate to glycerone phosphate. This protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). GPD1L is thought to affect trafficking of the cardiac sodium current to the cell surface. Mutations in GPD1L are the cause of sudden infant death syndrome (SIDS) and Brugada syndrome type 2, an autosomal dominant tachyarrhythmia.
- NCBI Accession
- NP_055956
-